Novo Nordisk takes on US Ozempic counterfeiter in trademark suit
MLex Summary: Novo Nordisk sued a weight loss clinic in the District of Nebraska, accusing the company of selling counterfeit Ozempic. The lawsuit brings claims of trademark infringement, false designation of...To view the full article, register now.
Already a subscriber? Click here to view full article